Central Data Catalog

Citations

1 Abdulla, Salim, Issaka Sagara, Steffen Borrmann, Umberto D'Alessandro, Raquel González, Mary Hamel, Bernhards Ogutu, Andreas Mårtensson, John Lyimo, Hamma Maiga, Philip Sasi, Alain Nahum, Quique Bassat, Elizabeth Juma, Lucas Otieno, Anders Björkman, Hans Peter Beck, Kim Andriano, Marc Cousin, Gilbert Lefèvre, David Ubben, and Zulfikarali Premji. "Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial." Lancet 372, no. 9652 (2008): 1819-1827.
2 Bassat, Quique, Modest Mulenga, Halidou Tinto, Patrice Piola, Steffen Borrmann, Clara Menéndez, Michael Nambozi, Innocent Valéa, Carolyn Nabasumba, Philip Sasi, Antonella Bacchieri, Marco Corsi, David Ubben, Ambrose Talisuna, and Umberto D'Alessandro. "Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial." PLoS ONE 4, no. 11 (2009).
3 Minzi, Omary Ms, Ignace A. Marealle, Seif Shekalaghe, Omar Juma, Eliford Ngaimisi, Mwajuma Chemba, Mastidia Rutaihwa, Salim Abdulla, and Philip Sasi. "Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product." Malar. J. (2013).
4 Olotu, A., G. Fegan, T. N. Williams, P. Sasi, E. Ogada, E. Bauni, J. Wambua, K. Marsh, S. Borrmann, and P. Bejon. "Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya." (2010).